Institutional Investor Sells $1.37M in Shares, Drops Below 5% Ownership
CAMP has more than doubled off its 52-week low of $1.305.
Summary
Institutional investor Everest Aggregator, LP sold approximately $1.37 million in Camp4 Therapeutics stock, reducing its stake below 5% after the company's recent positive news.
Key Events · Ownership and Investor Activity · CAMP
-
Significant Stake Reduction
Everest Aggregator, LP, an institutional investor, reduced its beneficial ownership in Camp4 Therapeutics to 4.8% of outstanding common stock, falling below the 5% threshold.
-
$1.37 Million in Stock Sales
The investor sold a total of 225,358 shares in open market transactions between January 12, 2026, and March 10, 2026, for an aggregate value of approximately $1.37 million.
-
Sales Followed Positive News
The largest sales occurred on March 9 and March 10, 2026, immediately after Camp4 Therapeutics announced a new collaboration with GlaxoSmithKline and secured $97.5 million in new capital on March 5, 2026.
Analysis · CAMP · Life Sciences
Everest Aggregator, LP, an institutional investor, significantly reduced its stake in Camp4 Therapeutics by selling approximately $1.37 million worth of common stock through a series of open market transactions. These sales, which occurred between January and March 2026, resulted in the investor ceasing to be a beneficial owner of more than 5% of the company's common stock as of March 9, 2026. Notably, the largest sales occurred immediately following the company's positive announcements on March 5, 2026, regarding a new GSK collaboration and securing $97.5 million in new capital. This reduction in institutional ownership could signal a shift in investment strategy or a move to lock in gains, potentially creating selling pressure.
How filings like this one have moved
In the 30 days to Sep 11, 2026, 30.5% of the 1993 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.21%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CAMP was trading at $5.60 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $290.7M. The 52-week trading range was $1.31 to $7.75. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.